argenx SE Investor Presentation Deck
November 2023, 25 slides
  1. argenx SE
  2. Related Decks
  3. Investor Presentation Decks
together we discover | argenx SE
forward looking statements | argenx SE
our mission is to transform severe autoimmunity redefining diseases as mediated raising expectations for what well controlled means for patients mediated | argenx SE
redefining what well controlled means for the patient we want to transform treatment for patients minimize treatment burden achieve broad and sustained responses regain control of their lives including professionally and socially | argenx SE
for generalized myasthenia alfa alfa and | argenx SE
simplifies treatment of in the community | argenx SE
driving sustained growth across the business consistent execution perpetual innovation | argenx SE
optimizing core launch strategies in combined net sales | argenx SE
dimensional expansion to reach patients globally by | argenx SE
innovating on the patient experience second generation future generations | argenx SE
reaching patients across the globe east | argenx SE
is just the beginning | argenx SE
advancing in on track to file in with launch targeted in adhere | argenx SE
advance trial topline data expected | argenx SE
pemphigus address trial topline data expected around | argenx SE
opportunity across multiple diseases | argenx SE
musk agonist with broad potential in neuromuscular disease clinical | argenx SE
innovation ecosystem | argenx SE
steady cadence of upcoming milestones through launches in | argenx SE
our culture | argenx SE
breadth and depth within pipeline | argenx SE
pots alpha trial topline data expected a | argenx SE
bullous pemphigoid ballad trial | argenx SE
myositis trial | argenx SE
for multifocal motor neuropathy advancing phase study to cohort | argenx SE
See More
argenx SE
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Autoimmune
Recent decks by argenx SE
Results
February 2024
Investor Conference
January 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
See all presentations by argenx SE (28 decks)
Related decks
Immix Biopharma
Investor Presentation
March 2024
Cabaletta Bio
Investor Presentation
October 2022
AbCellera
Investor Conference
January 2024
Roivant Sciences
Investor Presentation
September 2022
Compass Therapeutics
IPO
November 2020
Recent decks by argenx SE
See all presentations (28 decks)
Results
February 2024
Investor Conference
January 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
Immix Biopharma
Investor Presentation
March 2024
Cabaletta Bio
Investor Presentation
October 2022
AbCellera
Investor Conference
January 2024
Roivant Sciences
Investor Presentation
September 2022
Compass Therapeutics
IPO
November 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io